Stansberry research is touting a biotech pick that will cure a disease that kills 1 out of 4 people. What is it?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More InfoYour subscription is paid through your PayPal account.
To update your credit card or cancel, please log in to PayPal.com, go to your automatic payments, open the Stock Gumshoe payment, and make changes there.
More information here: Paypal — What Is an Automatic Payment and How Do I Update or Cancel One?
I was trying to figure this out myself, after doing a little research i think the ticker is ESPR.. @ $43/Share roughly…. The disease is heart disease, but their medicine targets high cholesterol, which I am guessing is a contributing factor to heart disease? Let me know what you guys think!
I think you’re right, we covered that one here: https://www.stockgumshoe.com/reviews/stansberry-venture/stansberry-ventures-most-valuable-pill-in-development-anywhere-pitch/